Atlas Trials

Safety Study on AdCD40L Gene Therapy for Bladder Cancer

Clinical trial NCT00891748 · COMPLETED

Trial details

NCT number
NCT00891748
Sponsor
Uppsala University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2006-11-01
Primary completion
2009-10-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.